Home » Lifestyle » CVS notes first-time COVID-19 vaccines are rising after a dip
CVS notes first-time COVID-19 vaccines are rising after a dip
Fox Business Flash top headlines for August 4
Check out what’s clicking on FoxBusiness.com.
Stocks in this Article
Pharmacy giant CVS announced an uptick in COVID-19 vaccinations during the second quarter, which in combination with testing, drove almost one-third in increased revenues in the three months leading up to June 2021, compared to the year prior.
CVS stated in a press release Wednesday that it has seen an increase in vaccinations after a dip. The company said that it has administered 30 million vaccines; 17 million of which were administered in the second quarter.
The press release also states that CVS’s revenue was $72.6 billion, up 11.1% from 65.3 billion in 2020’s second quarter due to the return of pre-pandemic normalcy.